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Abstract 
Background Endoscopic harvesting of the radial artery (RA) for coronary bypass surgery, is a well-known 
technique. However, its effect on graft patency and outcome is still unclear. Previous meta-analysis on 
the comparison between endoscopic RA harvesting (ERAH) vs open RA harvesting (ORAH) are mostly 
based on observational unmatched series and, thus, have major methodological limitations. We sought 
to investigate the impact of harvesting technique on RA graft patency and relevant clinical outcomes 
using a meta-analytic approach limited to randomized controlled trials and propensity matched studies.  
Method A systematic literature search was conducted using PubMed and MEDLINE to identify 
publications containing comparisons between ERAH and ORAH. Only randomized controlled trials and 
propensity matched series were included.  Data was extracted and analyzed with RevMan. Primary 
endpoints were wound complications, patency rate, early mortality, and long term mortality. 
Results Six studies comprising 743 patients were included in the meta-analysis. Of them 324 (43.6%) 
underwent ERAH and 419 (56.4%) ORAH. ERAH was associated with a lower incidence of wound 
complications (Odds Ratio:0.33, confidence interval 0.14-0.77; p=0.01). There were no difference in graft 
patency, early and long-term mortality between the two techniques.  
Conclusion ERAH significantly reduces wound complications and is associated with similar graft patency, 
and short and long-term mortality compared to ORAH.  
  
  
Introduction 
The left internal mammary artery (LIMA) has long been reported as the best conduit for coronary artery 
bypass grafting (CABG)1. The radial artery comes in second with comparable results to the saphenous 
vein in regards to short- and mid-term follow-up2,3. 
 
Endoscopic radial artery harvesting (ERAH) was recently developed in order to minimize the trauma and 
improve patient satisfaction.  Debate exists as to the better approach for radial artery harvesting. ERAH 
proponents emphasize the superior cosmetic and perioperative outcomes, whereas skeptics cite the 
lack of robust safety in clinical data on ERAH, especially in regard to graft patency.  Integrity of the 
endothelium has been reported to be responsible for the normal function of vessels, with any intimal 
damage leading to conduit failure that could precipitate recurrent angina and need for re-intervention4. 
 
Our aim in this meta-analysis is to identify all robust and relevant data from the current literature to 
compare the safety and the efficacy of ERAH versus ORAH for CABG. Our endpoints are wound 
complications, patency rate, in-hospital, and long term mortality. 
 
 
Materials and Methods 
Data sources and literature search strategy 
Literature review was conducted by two independent investigators (MR and MK) through PubMed 
online data sources (up to November 2016), using the search terms “endoscopic radial artery 
harvesting”. In addition, upon identifying other meta-analyses, systematic reviews, or RCTs, references 
were scanned for relevant articles and pertinent reviews (i.e., backward snowballing) to obtain further 
  
studies. For patency rate, we use the search terms “endoscopic radial artery harvesting, patency, 
outcome” in addition to backward snowballing. 
Study selection 
Inclusion criteria were: 1) randomized controlled trials or propensity matched studies (PSM); 2) 
comparing ERAH with ORAH in patients who underwent CABG and included interest outcomes such as 
wound complications, patency rate, 30 days/in-hospital mortality and long term mortality; 3) published 
full text manuscript and 4) written in English. 
For patency rate, inclusion criteria were 1) studies comparing ERAH with ORAH in CABG patients 
regardless of study design 2) angiographic follow-up of more than 50% of the overall patient population. 
Two investigators (MR and MK) independently reviewed the search results at the title and abstract level 
to determine whether the study met our inclusion criteria. In case of disagreement a third investigator 
(MG) reviewed the article and an agreement was negotiated. Pertinent articles were then retrieved. 
Primary outcomes 
Primary outcomes were wound complications, patency rate, early and long-term mortality. 
Due to differing definitions used in each study several outcome parameters were combined. In 
particular we included bleeding, hematoma, infection, as well as motor and sensory nerve deficits (hand 
pain and paresthesia) in the definition of wound complications and in-hospital and 30 days mortality in 
the definition of early mortality. 
Data extraction and Statistical analysis 
Microsoft Office Excel 2010 (Microsoft, Redmond, Washington) was used for data extraction. Data 
extraction of all included studies was performed independently by 2 investigators (MR, MK) and in case 
  
of disagreement a third investigator (MG) was included and an agreement was negotiated. Extracted 
variables were for matched populations only and included the follows: study name, publication year, 
study design, number of patients, interventions, age, sex, wound complications, patency rate, 30 
days/in-hospital mortality, and long-term mortality.   
Review Manager Version 5.3 was used to perform meta-analysis, and the estimated survival data were 
obtained from the Kaplan–Meier curves5 using GetData Graph Digitizer software. The data can be 
synthesized only when the number of studies equals or exceeds two. Measurement data reported as 
mean ± SD were adopted, and odds ratio (OR) was calculated.   
 
Individual and pooled OR with 95% confidence intervals (CI) were calculated by means of Mantel-
Haenszel (M-H) method. Risk difference (RD) was used as a summary estimate in case of 0 event studies. 
All the statistical results use random-effect models. Heterogeneity was assessed by X2-test and I2 and 
publication bias by funnel plots. The subgroup analysis was performed based on the study design 
(whether RCT or matched). Leave one out analysis was performed by Comprehensive Meta-Analysis 
software, version 2 (Biostat, Englewood, NJ, USA). 
 
Results 
Eligible studies and characteristics of studies 
An outline of the systematic review process is shown in Figure 1 and Supplementary Figure 1 
respectively. For clinical outcomes 139 studies were identified. After removal of duplicates 119 studies 
were screened. Thirty-three full text articles were assessed for eligibility. Among them 6 studies (four 
randomized controlled trials and 2 PSM studies met the inclusion criteria.  
  
Of the 743 patients included 324 (43.6%) underwent ERAH and 419 (56.4%) ORAH. The characteristics of 
the included studies are shown in Table 1 and 2. Studies included in patency rate analysis are shown 
Table 3. A total of 827 grafts were assessed by angiogram (458 in ERAH group and 369 in ORAH group) 
with pooled mean follow-up of 40.9 and 51.5-months in ERAH and ORAH respectively. 
Meta-analysis of postoperative outcomes 
Wound complications  
Overall ERAH was associated with a significantly lower risk of wound complication in comparison to 
ORAH (OR:0.33, CI 0.14-0.77; p=0.01). This difference was confirmed in the RCT studies subgroup (OR 
0.31, CI 0.11–0.92; p=0.03), but not in the PSM studies subgroup (OR:0.29, CI 0.04–2.12; p=0.21, Figure 
2A). These results were confirmed in the leave-one-out analysis. (Supplementary figure 2) 
Patency rate  
No differences were found in the RA patency rate between ERAH and ORAH groups (OR:1.36, CI 0.91–
2.04; p=0.14; Figure 2B). This was confirmed in RCT studies subgroup (OR:1.25, CI 0.60–2.60; p=0.55), 
and in the PSM studies subgroup (OR:1.41, CI 0.87–2.29; p=0.16; Figure 2B). These results were 
confirmed in the leave-one-out analysis. (Supplementary figure 2) 
Early and long-term survival outcome 
There was no statistical difference in early mortality between both groups (OR:0.78, CI 0.10-6.11; 
p=0.81; Figure 2C). This was confirmed in RCT studies subgroup (RD = -.0.00, CI = -0.04 - 0.04, p=1.00), 
and in the PSM studies subgroup (RD = -.0.00, CI = -0.02 - 0.02, p=1.00; Figure 2C). 
Similarly, no difference in 5-years mortality was seen between the groups (OR:0.59, CI 0.18-1.93; 
p=0.87; Figure 2D). No subgroup analyses were done as there was only 2 studies in this variable. 
  
Sensitivity analyses using leave-one-out analyses were done for all outcomes and confirmed our results 
(Supplementary figure 3) 
Table 4 summarizes the main findings of the analysis. Funnel plots of individual outcomes are shown in 
Figure 3. 
 
Discussion 
The radial (RA) contends with the right internal thoracic artery (RITA) for the role of best second arterial 
conduit. In a recent meta-analysis of propensity matched trials we found the use of the RITA was 
associated with a 25% survival benefit compared to the RA at mid-term follow-up6 . However, as in all 
meta-analysis of observational studies comparing different surgical techniques, a selection bias based on 
an unmeasurable surgeon’s “eye ball” test (with healthier patients receiving the more invasive bilateral 
internal thoracic artery (BITA) procedure) cannot be excluded. 
 
On the other hand the recently presented but yet unpublished 10-year results of the RAPCO trial 
showed better (although not significantly) patency rates and significantly better survival for the RA 
compared to the RITA7.  
Compared to the second ITA, the RA has the major advantage of not increasing the risk of sternal 
complications, an event with major clinical and economic implications. In a study by Omran and 
associates, that included 9000 CABG patients the occurrence of postoperative sternal complications 
increased operative mortality by 10-fold and incurred additional hospital costs8. In a meta-analysis by 
Dai and coworkers that included 173,000 patients, the rate of deep sternal wound infections was 
increased by 38% when the second ITA was utilized as a conduit9.   
  
Also, since the RA can be harvested simultaneously with other conduits, operative time is reduced when 
compared to the RITA. Overall, operations using the RA are technically easier than using the RITA and 
probably more friendly for surgeons with limited experience in complex arterial grafting. Together with 
the excellent long term results reported by RAPCO and us6,7, along with the above mentioned 
advantages of the RA and the increasing pressure toward multiple arterial revascularization, it is likely 
that the RA will experience a resurgence in the near future. 
The traditional harvesting of the RA has been open, but several reports have described an endoscopic 
harvesting technique.  
An abundant body of evidence related to harvesting of the saphenous vein testifies to how the 
endoscopic harvesting is more traumatic and can potentially affect the patency. The RA is more fragile 
than the saphenous vein and endothelial integrity is of particularly importance in the RA which has a 
recognized early spastic tendency. For these reasons, the concerns regarding vessel damage are even 
higher for the RA when using the endoscopic approach. 
The comparative studies between the two techniques have yielded different results and no consensus 
about the ideal harvesting method currently exists. In a propensity score matched (PSM) study by Navia 
and colleagues, found no difference between the two techniques in terms of wound infection and 
neurological deficits3. However, Bisleri and coauthors found that open radial artery harvesting was 
associated with increased wound infection (7.3% vs 0.0%; p=0.007), poorer wound healing on Hollander 
scale (3.3 vs 4.7, p<0.001), and increased prevalence of paresthesia at late term follow-up (19.5% vs 
3.6%; p<0.001)10.  
So far two meta-analysis have compared endoscopic vs open harvesting techniques for the RA. The first 
by Wu and colleagues examined 10-studies (8-observational, 2-randomized control trials) and included 
2782 patients11. Results showed that ERAH was associated with lower incidence of wound infection 
  
(OR:0.31, CI 0.13-0.74; p=0.008) but similar incidence of hematoma formation (OR:0.32, CI 0.07-1.39; 
p=0.13). Post-operative paresthesia was not examined. In the second study, Cao and coworkers 
examined 12-studies (1 RCT and the remaining 11 were observational) and included 3314 patients12. 
Their results showed that ERAH had significantly lower incidence of wound infections (RR:0.36, CI 0.16-
0.82; p=0.01), hematoma formation (RR:0.45; CI 0.26-0.77; p=0.004), and paresthesia (RR:0.77, CI 0.61-
0.99; p=0.04).  
When examining graft patency and all-cause mortality, Wu and colleagues11 found that ERAH offered no 
advantage when compared to ORAH (OR:0.81, CI 0.54-1.21; p=0.3 and OR:1.06, CI 0.26-4.38; p=0.94, 
respectively). Similarly, Cao and coworkers12 found that using an endoscopic technique did not improve 
mortality (0.3% vs 0.5%; p=0.55), incidence of myocardial infarct (0.8% vs 1.0%; p=0.62), and graft 
patency (2-studies, 88.7% vs 85.5%; p=0.24 and 2-studies, 75.9% vs 78.1%; p=0.97). 
However, both studies have major methodological limitations as they included mostly unmatched 
observational studies13. Our meta-analysis focused only on RCT or PSM studies in order to provide a 
summary of the best available evidence and to avoid the recognized limitations of meta-analysis of 
observational studies. 
Our results showed a significantly lower incidence of wound complications in the ERAH series with no 
difference in graft patency rate, short and long term mortality.  
Conclusion 
ERAH significantly reduces wound complications and is associated with similar graft patency, and short 
and long-term mortality compared to ORAH.  
  
  
Figure legend 
Figure 1. PRISMA flowchart for clinical outcomes. 
Figure 2. Forest plot of comparison ERAH vs ORAH: A, Wound complications; B, Patency rate; C, In 
hospital/30-day mortality; D, Long-term mortality. 
Figure 3. Funnel plot for publication bias: A, Wound complications; B, Patency rate; C, In hospital/30-day 
mortality; D, Long-term mortality. 
Supplementary figure 1. PRISMA flowchart for angiographic patency. 
Supplementary figure 2. Leave-one-out analysis for: A, Wound complications; B, Patency rate; 
C, In hospital/30-day mortality; D, Long term mortality. 
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Table 1. Overview of included studies  
 
Study Year  Country Centers Study period Type of study 
Bisleri10 2016 Poland, Italy Multicenter 2005-2007 Matched 
Burns14 2015 Canada Western University 
Ontario 
2005-2007 RCT 
Navia15 2011 USA Cleveland Clinic, Ohio 2002-2004 Matched 
Nowicki16 2011 Poland Multicenter 2004-2007 RCT 
Rudez17 2007 Croatia Dubrava University 
Hospital, Zagreb 
2002-2004 RCT 
Shapira18 2006 USA Boston Medical Center, 
MA 
Till 2005 RCT 
 
RCT, randomized controlled trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2. Overview of included studies 
 
EF%, ejection fraction; ERAH, Endoscopic Radial Artery Harvesting; DM diabetes mellitus; HTN, hypertension; NR, not reported; ORAH, Open Radial Artery Harvesting; PVD, peripheral vascular 
disease; QoL, quality of life; 2-VD, 2-vessel disease; 3-VD, 3-vessel disease 
 
 
 
 
 
 
 
 
Study Age (mean±SD) 
ERAH vs ORAH 
Median  
follow-up 
Males (%) 
ERAH vs ORAH 
DM (%) 
ERAH vs ORAH 
HTN (%) 
ERAH vs ORAH 
2-VD (%) 
ERAH vs ORAH 
3-VD (%) 
ERAH vs ORAH 
PVD (%) 
ERAH vs ORAH 
Dyslipidemia (%) 
ERAH vs ORAH 
EF (%) 
ERAH vs ORAH 
Urgent 
operation (%) 
ERAH vs ORAH 
Outcomes 
Bisleri10 62.1±10.2  
vs 70.5±8.3 
NR 74.7 vs 74.1 23.1 vs 34.6 73.1 vs 67.9 36.5 vs 39 63.4 vs 61.7 26.8 vs 34.6 63.4 vs56.8 <40% 
15.8 vs 19.8 
NR Wound 
complications, 
Mortality 
Burns14 57.8 vs 57.9 79.2±8.6 months 90 vs 93.2 25.1 vs 20.4 NR NR NR 0 vs 3.4 NR NR 48.3 vs 54.2 Mortality, 
Patency, QoL 
Navia15 60 ±9.9  
vs 62± 9.1 
NR 90 vs 95 18 vs 19 77 vs 79 NR NR 41 vs 43 NR 50 ±13 vs 
47±13 
NR Wound 
complications, 
Mortality, 
Organs failure 
Nowicki16 <70 years in 
both 
3 years 88 vs 91 20 vs 18 NR NR NR NR NR NR NR Wound 
complications, 
Mortality, 
Patency, 
Endothelial 
integrity 
Rudez17 60.5 ± 9.2  
vs 61.2 ± 9.8 
37±7  
months 
64 vs 72 32 vs 24 56 vs 60 NR NR NR 76 vs 68 NR NR Wound 
complications, 
Mortality 
Shapira18 60±10  
vs 62±12 
NR 66.7 vs 72.2 41.7 vs 44 72 vs 80.6 NR NR 22.2 vs 22 88.9 vs 94 54±11 vs 53±13 NR Wound 
complications, 
Mortality, 
Histological 
changes, 
Adhesion 
molecule 
expression & 
histologic 
changes 
  
Table 3. Studies included in patency rates analysis 
 
Study Year  ERAH No.  ERAH - Patent (%) ORAH No. ORAH - Patent (%) P value* 
Burns14; RCT 2015 34 31(91.2) 32 28(87.5) 0.63 
Nowicki16; RCT 2011 100 88(88) 100 86(86) 0.67 
Dimitrova19 2010 148 124(83.8) 119 94(79) 0.31 
Ito20 2009 50 48(96) 50 47(94) 0.65 
Kim21 2007 76 74(97.4) 18 17(94.4) 0.53 
Bleiziffer22 2007 50 39(78) 50 36(72) 0.49 
 
ERAH, Endoscopic Radial Artery Harvesting; ORAH, Open Radial Artery Harvesting  
* calculated using Chi (X2) square 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 4. All outcomes of interest 
Outcome Number of studies Cases OR/RD 95% CI Heterogeneity Test for overall effect Favors group 
Wound complications 5 624 OR=0.33 0.14-0.77 P=0.51, I2=0% Z=2.57, P=0.01 ERAH 
Patency rate 6 827 OR=1.36 0.91-2.04 P=1.00, I2=0% Z=1.49, P=0.14 None 
In-hospital/ 
30-day mortality 
5 543 RD =-0.00 -0.02-0.01 P=0.97. I2=0% Z=0.33, P=0.74 None 
Long-term mortality 2 240 OR=0.59 0.18-1.93 P=0.87, I2=0% Z=0.87, P=0.39 None 
 
CI, confidence interval; OR, odds ratio; RD, risk difference; ERAH, Endoscopic Radial Artery Harvesting 
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